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Abstract
According to World Cancer Research Fund International/American Institute for Cancer Research, it is ‘probable’ that dairy products decrease
the risk of colorectal cancer (CRC). However, meta-analyses restricted to women have not shown associations between milk intake and risk of
CRC. The aim of this study was to examine the association between milk intake and risk of CRC, colon cancer and rectal cancer among
women. Data from 81 675 participants in the Norwegian Women and Cancer Cohort Study were included, and multivariable Cox proportional
hazard regression models were used to investigate milk intake using two different analytical approaches: one that included repeated
measurements and one that included baseline measurements only (872 and 1084 CRC cases, respectively). A weak inverse association
between milk intake and risk of colon cancer may be indicated both in repeated measurements analyses and in baseline data analyses. Hazard
ratios (HR) for colon cancer of 0·80 (95% CI 0·62, 1·03, Ptrend 0·07) and 0·81 (95% CI 0·64, 1·01, Ptrend 0·03) and HR for rectal cancer of 0·97
(95% CI 0·67, 1·42, Ptrend 0·92) and 0·71 (95% CI 0·50, 1·01, Ptrend 0·03) were found when comparing the high with the no/seldom milk intake
group in energy-adjusted multivariable models. Our study indicates that there may be a weak inverse association between milk intake and risk
of colon cancer among women. The two analytical approaches yielded different results for rectal cancer and hence CRC. Our study indicates
that the use of single or repeated measurements in analyses may influence the results.
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The incidence rates of colorectal cancer (CRC) vary greatly across
the world(1), with high-income countries such as Norway having
the highest incidence rates (Norway, age-standardised (world)
incidence rate 2012: 35·8/100 000)(1). Lifestyle factors such as
eating habits are believed to influence the risk of CRC(2,3). The
World Cancer Research Fund International/American Institute
for Cancer Research has reported that, based on current evidence,
it is ‘probable’ that dairy products decrease the risk of CRC(3). As
milk consumption accounts for a large proportion of dairy
product consumption in most countries, this finding for dairy
products may, to a large extent, be driven by milk consumption(4).
Milk intake has been found to be inversely associated with the
risk of CRC when analysing both sexes combined in meta-
analyses, but not when women have been studied alone(4–6). No
association has been found in meta-analyses when investigating
milk intake and the risk of colon cancer among women, whereas
different results have been found when investigating milk intake
and the risk of rectal cancer among women(4–6).
Different mechanisms for an association between the
consumption of dairy products and the risk of CRC have
been examined, including mechanisms involving Ca, vitamin D
and properties of fermented dairy products(7–11). Milk also
contains other constituents, such as conjugated linoleic acid and
sphingomyelin, which may affect the risk of CRC(12,13).
However, the main hypothesis for the observed association
between dairy products and the risk of CRC relates to Ca(4).
The per capita milk intake in Europe is high (>150 kg/capita
per year)(14), but the milk intake in Norway almost halved
between 1989 (175 kg/capita per year) and 2013 (92 kg/capita
per year)(15,16). Norwegian women used to have one of
the highest intakes of cow’s milk in Europe (177 g/d)(17) and
large variation in intake (0–>270 g/d)(18). The Norwegian
Women and Cancer (NOWAC) Cohort Study has repeated
measurements on dietary information for many of its partici-
pants. The aim of our study was to examine the association
between milk intake and the risk of CRC, colon cancer and
Disclaimer: Some of the data in this article are from the Cancer Registry of Norway. The Cancer Registry of Norway is not responsible for the analysis or
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rectal cancer among women based on data from the NOWAC
Cohort Study. We did this by applying two different analytical
approaches: one that included repeated measurements to
account for changes in milk intake and one that, concurrent to
the main body of the existing literature, included baseline
data only.
Methods
The Norwegian Women and Cancer Cohort Study and
study sample
Between 1991 and 2007, approximately 172 000 women were
enrolled in the NOWAC Study, a nationwide prospective
cohort study. The women have been sampled randomly
from the National Registry in Norway. All study participants
completed a self-administered questionnaire at enrolment,
and follow-up questionnaires are mailed approximately
every 6th year thereafter. As questionnaires sent before 1996
did not include a detailed FFQ, only the 98 355 NOWAC parti-
cipants who answered a questionnaire between 1996 and
2005 (set as the baseline questionnaire in the present
study) were eligible for inclusion in the present study. Some of
these women also completed a similar questionnaire
approximately 6 years later, which was set as the follow-up
questionnaire.
Informed consent was obtained from all participants in the
NOWAC Study, and the study has been approved by the
Norwegian Data Inspectorate and the Regional Committee for
Medical Research Ethics. The NOWAC Study and a number of
validation studies have been described earlier(19–25).
We excluded participants with a history of invasive cancer
(except non-melanoma skin cancer) at baseline (n 4345), as
well as those with International Classification of Diseases for
Oncology (ICD-O) tumour code 9 (malignant, uncertain whe-
ther metastatic or primary site) (n 19), ICD-O code 6 (malignant,
metastatic site) (n 1) and those with a daily energy intake of
<2·5MJ (n 1581) or >15·0MJ (n 226) at baseline or follow-up.
We further excluded women with missing information on the
following variables at baseline: milk intake (n 1302), all six
questions about spread/cold cut intake on bread (n 694), yogurt
intake (n 1030) and self-reported height (n 729). We then
excluded women with missing information at baseline or
follow-up on self-reported weight (n 2789) or smoking duration
(n 650). Finally, we excluded those with uncertainty about
smoking duration (n 3288) and those with a BMI <13·0 kg/m2
(n 4) or >60·0 kg/m2 (n 22) at baseline or follow-up. Thus, the
final study sample with baseline information consisted of
81 675 women.
Follow-up data on dietary intake and other exposure
variables were available for 49 274 women, but censoring
owing to incident cancer/emigration/death (n 1691) left 47 583
women at follow-up. The reasons for lack of follow-up
data were as follows: not all of the women had participated
long enough to be invited to complete a follow-up ques-
tionnaire, and some of the eligible women did not complete the
follow-up questionnaire or they had missing information on
dairy product variables (milk, hard white cheese or yogurt)
at follow-up. Fig. 1 shows the flow chart of the participants in
the study.
Assessment of milk intake and other variables
Age was extracted through linkage to the National Registry in
Norway. Other information was taken from the baseline and
follow-up questionnaires. Self-reported height and weight, both
of which have been validated(24), were used to calculate BMI.
The variable of smoking duration was created by combining
information on smoking history and smoking status.
Self-reported physical activity level (global score including
physical activity at home, work, exercise, walking and so on)
was reported on a 10-point scale, which has been found valid to
rank physical activity level in the NOWAC Study(19). Informa-
tion on education was taken from the NOWAC enrolment
questionnaire.
Dietary information was taken from the semi-quantitative
FFQ included in the NOWAC questionnaires. The FFQ aimed
at recording usual food intake. Average consumption of
foods during the last year was reported in the FFQ by ticking
fixed frequencies that were chosen to fit the Norwegian
diet. Portion sizes were reported in household units (e.g.
tablespoons), decilitres or natural units (e.g. an orange).
According to a validation study including 238 women, the
NOWAC FFQ’s ability to rank participants was good for foods
eaten frequently(20). A validation study involving fatty acids
and marine foods has also been performed in the NOWAC
Study(25), and a test–retest reproducibility study found that
the level of reproducibility was within the range found for
similar FFQ(23). The calibration coefficient1 between four
repeated 24-h dietary recalls and the FFQ was 0·96 for milk
intake from a glass (unpublished results). We multiplied
portion size by the mean intake frequency to calculate the
consumption of each food in grams. The lowest value in the
frequency option was used for the uppermost category of a
food (e.g. a frequency option of ‘4+ ’ was categorised as
consumption of ‘4’ in our analyses). In these calculations, a
Norwegian Weight and Measurement Table(26) was used. Daily
intake of nutrients and energy was computed based on the
Norwegian Food Composition Table(27). Missing portion
sizes were treated as the smallest portion unit option in the
questionnaire, and missing frequencies were treated as no
consumption. We used a program developed for SAS at the
Institute of Community Medicine, UiT The Arctic University of
Norway, to calculate daily intakes of foods, energy and nutri-
ents per participant.
In this study, milk intake was assessed as milk consumed from
a glass (milk intake). The FFQ did not distinguish between
fermented and non-fermented milk. Other types of milk con-
sumption (e.g. milk used when cooking, milk in coffee) were not
considered in our calculation of milk intake. Participants reported
how many glasses of each type of milk (whole-fat milk, semi-
skimmed milk, extra semi-skimmed milk and skimmed milk) they
consumed on average during the last year (no/seldom, 1–4
1 Calculation of calibration coefficient: regression of the 24-h dietary recall
data (dependent variable) on the FFQ data (independent variable) in linear
regression model(20).
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glasses/week, 5–6 glasses/week, 1 glass/d, 2–3 glasses/d and
≥4 glasses/d). The question on extra semi-skimmed milk
(vitamin-D-fortified) was included in the questionnaire from the
year 2000, when it was introduced on the market. Women
who reported a milk intake of ‘no/seldom’ were categorised as
non-consumers. One glass of milk was estimated to weigh 210g
(based on unpublished results from a validation study(20)).
Some dietary questions have been added to the FFQ over the
years owing to new products being available on the market,
improvements of the questionnaire and specific hypotheses.
Consumption of red meat included chops, steak and roast
meat (beef, mutton, pork), reindeer meat and lean sandwich
meat. Consumption of processed meat included meatballs,
hamburgers, sausages, liver pate, processed sandwich meats
and bacon. Some of the questionnaires did not contain ques-
tions on bacon and reindeer meat.
Classification of colorectal cancer cases and vital status
The unique national identification number given to all Norwegian
citizens was used to link study participants to the Cancer Registry
of Norway for cancer and to the National Registry in Norway for
vital status (alive, dead, emigrated). The Cancer Registry of
Norway classified CRC cases according to the International
Classification of Diseases, Seventh Revision (ICD-7). The CRC
cases were classified according to anatomic subsite: CRC (ICD-7
code 153.0–154.0); colon cancer (ICD-7 code 153.0–153.9:
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Fig. 1. Flow chart of women included in the present analyses. * n 1691 of these women had baseline and follow-up data.
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splenic flexures, descending and sigmoid colon, recto-sigmoid
junction and unspecified location); and rectal cancer (ICD-7 code
154.0). Cancers with ICD-7 code 154.1 (anal canal tumours) were
not included in the analyses. Furthermore, only cancer with ICD-O
tumour code 3 (malignant, primary site) were regarded as CRC.
Statistical analysis
Descriptive characteristics of the study participants at baseline
and at follow-up are presented as percentages or median values
and 5th and 95th percentiles. The associations between milk
intake and the risk of CRC, colon cancer and rectal cancer were
investigated by Cox proportional hazards regression models
with age as the time scale, using two different analytical
approaches. One approach consisted of measurements from
two points in time when available (repeated measurements
analyses). In the other approach, we investigated whether
running the same models using baseline measurements only
(baseline data analyses) affected the results. All models were
stratified by baseline questionnaire subcohort (i.e. whether
baseline questionnaire was in the form of the NOWAC enrol-
ment questionnaire or of the first NOWAC follow-up ques-
tionnaire). Hazard ratios (HR) and 95% CI were calculated.
The same study sample (n 81 675) was used for repeated
measurements analyses and baseline data analyses.
In the repeated measurements analyses, we used baseline
data on dietary and non-dietary information until follow-up,
and follow-up data on dietary and non-dietary information
thereafter. That is, we used baseline data until the diagnosis of
any incident cancer (except for non-melanoma skin cancer),
emigration, death, follow-up, whichever occurred first. After
that, follow-up data for milk intake and all potential con-
founders except education were used in the analysis until the
diagnosis of any incident cancer (except for non-melanoma
skin cancer), emigration, death or the end of the study
(31 December 2013), whichever occurred first. Participants
without follow-up data (not yet invited to complete follow-up
questionnaire, not returning follow-up questionnaire or
missing information on dairy product variables in follow-up
questionnaire) were censored at follow-up. In the repeated
measurements analyses, person-years were calculated from the
start of the study to the end of the study (31 December 2013),
diagnosis of any cancer (except non-melanoma skin cancer),
death or emigration or no follow-up data, whichever
occurred first.
In baseline data analyses, we used baseline data for milk
intake and all the other variables until diagnosis of any incident
cancer (except for non-melanoma skin cancer), death, emigra-
tion or the end of the study (31 December 2013), whichever
occurred first. Person-years were calculated in the same way as
in the repeated measurements analyses, with the exception that
no one was censored at follow-up.
Three Cox proportional hazards regression models (age-
adjusted model, multivariable model and energy-adjusted
multivariable model) were established with milk intake as the
exposure. In the multivariable model, we adjusted for pre-
defined potential confounders for CRC that we identified
through a literature review (BMI, smoking, yogurt, hard white
cheese, fibre from foods, processed meat, red meat and
alcohol). In the energy-adjusted multivariable model, we adjusted
for everything in the multivariable model plus energy intake.
Physical activity level has been found to decrease the risk of
CRC(3). However, HR for CRC, colon cancer or rectal cancer
hardly changed in the age-adjusted or the multivariable model
(in both repeated measurements analyses and baseline data
analyses) when adjusting for physical activity level among those
with this information available (n 72 071). Owing to this, the
frequency of missing information on physical activity level
(n 9604) and the moderate power of our study, this variable
was not included in the multivariable model.
Milk intake was calculated as the sum of the four different
milk types in grams. Milk intake was modelled categorically;
those reporting no/seldom intake made up one group
(no/seldom intake group), and the rest were divided into three
groups (tertiles): low milk intake group, >no/seldom to
≤165 g/d; medium milk intake group, >165 to ≤240 g/d; and
high milk intake group, >240 g/d. Furthermore, the following
variables were modelled categorically: smoking (never, smok-
ing<30 years, smoking≥ 30 years), duration of education
(<10, 10–12, >12 years), hard white cheese (quartiles), yogurt
(no/seldom, <50 g/d, ≥50 g/d) and traditional whey cheese
(no/seldom, <15 g/d, ≥15 g/d). Finally, the following variables
were modelled continuously: physical activity level (on a
ten-point scale), BMI (kg/m2), fibre from foods (g/d), processed
meat intake (g/d), red meat intake (g/d), Ca from foods other
than dairy products (yogurt, hard white cheese, milk) (mg/d),
vitamin D intake from cod liver oil and from foods except
extra semi-skimmed milk (vitamin-D-fortified) (µg/d), alcohol
consumption (g/d) and energy intake (kJ/d).
When investigating the associations between milk intake and
risk of CRC, colon cancer and rectal cancer, the predefined
models (age-adjusted, multivariable, energy-adjusted multi-
variable) were used. The robustness of the associations for CRC,
colon cancer and rectal cancer were investigated by running the
multivariable model plus one possible confounder identified
through a literature review (traditional whey cheese, Ca from
foods except dairy products (yogurt, hard white cheese, milk),
vitamin D from cod liver oil and from foods except vitamin-D-
fortified milk). We also ran analyses using the multivariable
model less one variable (BMI, smoking, yogurt, hard white
cheese, processed meat, red meat, fibre from foods, alcohol
consumption). Moreover, we investigated whether adjustment
for duration of education (excluding women with >29 years of
education (n 23), <7 years of education (n 314) and women
with missing information on education (n 4132)) in the multi-
variable model affected the risk estimates. To eliminate the
influence of pre-existing disease on the risk estimates, we
excluded all CRC cases that occurred 1 year or less from
baseline and from the start of follow-up (in the multivariable
model and the energy-adjusted multivariable model). Finally, in
the subsample of women with complete repeated measure-
ments (i.e. complete baseline and follow-up data) (n 49 274),
we analysed the data using repeated measurements analyses
and baseline data analyses.
We found only minor effects on the estimated HR of milk
intake in the multivariable model for CRC, colon cancer and
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rectal cancer when the continuous variables were modelled as
categorical variables. Owing to this finding and moderate
power in our study, these variables were used as continuous
variables in the analyses. Possible correlations between the
variables included in the Cox proportional hazards regression
models were investigated by the variance inflation factor and
Spearman’s correlation coefficient at baseline. The proportional
hazards assumption was investigated by a log-log survival plot
and Schoenfeld residuals. Possible predefined interaction
effects (milk v. processed and read meat, respectively(28)) were
examined in the multivariable model for CRC and colon cancer
using the likelihood ratio test comparing the multivariable
model including a product term and the multivariable model.
To examine linear trends in risk, we made a continuous variable
by calculating the average intake of milk within each milk
intake group and including this continuous variable in the
analyses. A P value of less than 0·05 was considered statistically
significant.
STATA (StataCorp) version 14.0 was used in the analyses.
Results
Sample characteristics
In the repeated measurements analyses, there were 922 583
person-years of observation, and 617 (71%) and 255 (29%)
incident cases of colon cancer and rectal cancer, respectively. In
the baseline data analyses, there were 1 059 797 person-years of
observation, and 771 (71%) and 313 (29%) incident cases of
colon cancer and rectal cancer, respectively. Median time under
study was 10 (range 1–17) and 15 (range 1–17) years, and the
median age at CRC diagnosis was 62 (range 43–85) and 63
(range 43–86) years, in repeated measurements analyses and
baseline data analyses, respectively.
The median and mean milk intake was 165 and 212 g/d at
baseline and 75 and 171 g/d at follow-up, respectively. Fur-
thermore, the median and mean total Ca intake from foods
(including milk) was 704 and 753 g/d at baseline and 661 and
715 g/d at follow-up, respectively. At baseline, the median age
(51 years, range: 41–70 years) and the median BMI was the
same in all milk intake groups (Table 1). The median milk
intake at baseline was 0, 75, 210 and 525 g/d in the no/seldom,
low, medium and high milk intake groups, respectively. At
follow-up, median milk intake declined among those with
medium and high milk intake at baseline, whereas median milk
intake among those in the no/seldom and low intake group at
baseline was the same at follow-up. In all, 53% of the women
did not change milk intake group between baseline and follow-
up, whereas 33% changed to a lower and 14% to a higher milk
intake group (Table 2). The median intake of Ca from foods was
higher among those drinking more milk at baseline. The
Spearman’s correlation coefficient was 0·67 between milk
intake and Ca from foods at baseline. The median age at
baseline was higher among the CRC cases than in the total study
sample (Table 3), whereas median BMI was the same in the
total study sample and among the CRC cases at baseline.
Women diagnosed with CRC had shorter duration of education
when compared with the total study sample.
Main analyses
When examining the associations between milk intake and risk
of CRC, colon cancer and rectal cancer, a weak inverse asso-
ciation may be indicated between milk intake and risk of colon
cancer (Table 4). For rectal cancer, and hence CRC, different
results were found depending on the analytical approach. We
found no association between milk intake and risk of rectal
cancer in the repeated measurements analyses, whereas a weak
protective effect may be indicated in baseline data analyses.
Energy-adjusted multivariable models in repeated measure-
ments and baseline data analyses showed HR for CRC of 0·85
(95% CI 0·69, 1·05, Ptrend 0·14) and 0·78 (95% CI 0·64, 0·94,
Ptrend <0·01), respectively, when comparing the high with the
no/seldom milk intake group. When performing the same
comparisons in energy-adjusted multivariable models, the HR
for colon and rectal cancer were 0·80 (95% CI 0·62, 1·03, Ptrend
0·07) and 0·97 (95% CI 0·67, 1·42, Ptrend 0·92) in the repeated
measurements analyses, respectively, and in the baseline data
analyses the HR were 0·81 (95% CI 0·64, 1·01, Ptrend 0·03) for
colon cancer and 0·71 (95% CI 0·50, 1·01, Ptrend 0·03) for rectal
cancer. The HR for milk intake in the multivariable model were
not substantially different from the HR in the energy-adjusted
multivariable model for CRC, colon cancer or rectal cancer in
repeated measurements analyses or baseline data analyses.
Additional analyses (robustness)
Performing analyses using the multivariable model plus one
variable (traditional whey cheese, Ca from foods except dairy
products, vitamin D from cod liver oil and from foods except
vitamin-D-fortified milk), or less one variable (BMI, smoking,
yogurt, hard white cheese, processed meat, red meat, fibre from
foods, alcohol consumption), did not change the risk estimates
substantially for CRC, colon cancer or rectal cancer in repeated
measurements analyses or baseline data analyses, nor did the
addition of education. Excluding all CRC cases that occurred
within 1 year of baseline in baseline data analyses did not
substantially alter the risk estimates for CRC, colon cancer or
rectal cancer. The same was found when these cases plus all
CRC cases that occurred within 1 year of follow-up were
excluded from repeated measurements analyses. Thus, these
CRC cases were included in the baseline and repeated mea-
surements analyses, respectively. No effect modification by
processed meat intake or red meat intake was found in the
multivariable model for CRC or colon cancer in either the
repeated measurements analyses or the baseline data analyses.
In the subsample (n 49 274) of women with complete base-
line and follow-up information, the HR for colon cancer when
comparing the high with the no/seldom intake group in the
energy-adjusted multivariable model were 0·72 (95% CI 0·53,
0·99, Ptrend 0·06) and 0·76 (95% CI 0·56, 1·04, Ptrend 0·05) in
repeated measurements analyses and baseline data analyses,
respectively (Table 5). Comparing these same groups yielded
HR for rectal cancer in the energy-adjusted multivariable model
of 0·78 (95% CI 0·49, 1·23, Ptrend 0·48) and 0·63 (95% CI 0·40,
1·00, Ptrend 0·05) in repeated measurements analyses and
baseline data analyses, respectively.
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In this large cohort study of Norwegian women, we studied the
association between milk intake and the risk of CRC, colon
cancer and rectal cancer using both repeated measurements
analyses and baseline data analyses. Our study indicates that
there may be a weak inverse association between milk intake
and risk of colon among women. For rectal cancer, and hence
CRC, different results were found depending on the analytical
approach. Our study suggests that further attention ought to be
Table 1. Selected characteristics of the study sample by milk intake at baseline (1996–2005) in the Norwegian Women and Cancer Cohort Study, n 81675
(Medians and 5th–95th percentiles; numbers; percentages)
Milk intake group*










Range of total milk intake at baseline (g/d) 0–0 75–165 210–240 285–2520
Number of women at baseline 19 312 25 915 15710 20 738
Number of women at follow-up 14 397 15 963 8286 8937
Age at baseline (years) 51 42–60 51 42–63 51 42–64 51 42–65
Age at follow-up (years) 56 48–67 56 48–68 57 48–70 56 48–70
BMI at baseline (kg/m2) 24 20–32 24 20–32 24 20–32 24 20–32
BMI at follow-up (kg/m2) 25 20–33 25 20–33 25 20–32 25 20–33
Smoking at baseline (%)
Never
Baseline 33 36 39 39
Follow-up 35 38 41 41
<30 years
Baseline 48 46 44 43
Follow-up 41 38 37 35
≥30 years
Baseline 19 19 17 18
Follow-up 25 24 22 24
Physical activity level at baseline (%)†
Low
Baseline 14 13 11 12
Follow-up 13 12 10 12
Medium
Baseline 71 73 75 73
Follow-up 69 72 73 71
High
Baseline 15 14 14 15
Follow-up 18 16 16 17
Duration of education at baseline (%)‡
<10 years 21 26 23 27
10–12 years 36 35 34 35
>12 years 43 40 43 38
Total milk intake at baseline (g/d) 0 0–0 75 75–165 210 210–240 525 285–840
Total milk intake at follow-up (g/d) 0 0–165 75 0–375 188 0–525 240 0–810
Yogurt at baseline (g/d) 0 0–100 25 0–100 25 0–100 25 0–100
Hard white cheese at baseline (g/d) 20 0–64 14 0–50 20 0–50 20 0–50
Traditional whey cheese at baseline (g/d) 4 0–38 4 0–38 4 0–38 4 0–38
Fibre from foods at baseline (g/d) 21 11–33 21 11–32 21 12–32 22 12–34
Processed meat at baseline (g/d) 28 4–73 28 4–71 30 4–71 32 7–75
Red meat at baseline (g/d) 13 0–37 13 0–36 13 0–35 13 0–36
Ca from foods at baseline (mg/d)§ 502 255–960 601 353–1034 710 477–1119 1052 752–1562
Ca from foods at follow-up (mg/d) 523 266–1026 610 323–1113 678 374–1203 869 422–1477
Ca from milk at baseline (mg/d) 0 0–0 75 75–165 210 210–240 525 285–840
Ca from milk at follow-up (mg/d) 0 0–174 75 0–381 201 0–525 244 0–840
Ca from foods other than dairy products at baseline (mg/d)|| 312 177–517 320 182–520 323 184–522 336 192–538
Ca from foods other than dairy products at follow-up (mg/d) 323 179–536 331 187–535 333 190–532 343 194–547
Vitamin D from foods other than vitamin-D-fortified milk
at baseline (µg/d)¶
5·3 1·6–26·5 5·7 2·0––27·0 6·1 2·0–28·6 6·9 2·2–29·0
Alcohol at baseline (g/d) 2 0–12 2 0–12 2 0–12 2 0–11
Energy intake at baseline (kJ/d) 6420 3866–9708 6617 4026–9883 6877 4397–10 027 7758 5146–11166
Energy intake at follow-up (kJ/d) 6534 3847–10015 6745 4052–10 155 6941 4238–10 372 7444 4560–11017
* Milk intake group: no/seldom: 0 (no/seldom); low: >no/seldom to ≤165g/d; medium: >165g/d to ≤240g/d; high: >240g/d.
† n 72071 at baseline.
‡ n 77206 at baseline.
§ Milk is included in Ca from foods.
|| Dairy products= total milk + hard white cheese+ yogurt.
¶ Vitamin D from cod liver oil is included in vitamin D from foods.
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given to the use of single or repeated measurements when
investigating the association between milk intake and the risk of
CRC, colon and rectal cancer, as individuals may change their
milk intake over time.
The main strengths of the study include its prospective
design, the use of information on milk intake and many
potential confounders from two time points for many of the
participants, and almost complete information on the end
points (cancer incidence, death, emigration) through linkage to
national registries. The Cancer Registry of Norway has almost
complete information on CRC cases and a high proportion of
CRC are morphologically verified(29). Moreover, the FFQ
used in this study has been validated(20,25), and milk intake in
Norway has traditionally been high with a large variation.
Furthermore, the calibration coefficient between 24-h dietary
recalls and the FFQ for milk was 0·96 (unpublished results), and
in a test–retest study of the FFQ the agreement for whole-milk
intake it was 85%(23). The NOWAC Study is a nationwide study
with participants who were randomly sampled from the
National Registry in Norway. Studies of external validity have
shown a somewhat higher educational level among NOWAC
respondents than among NOWAC invitees, but no major
selection bias was found(22).
There are also several limitations in our study. Exposure
information is a potential weakness. In general, it is difficult to
collect precise information about dietary intake. Although we
measured milk intake at two time points, changes in milk intake
between the measures or after the second dietary assessment
are not registered, and measurement error owing to this cannot
be excluded. Moreover, we only included milk consumption
from a glass, and thus milk used in coffee or elsewhere was not
included. We could not analyse non-fermented and fermented
milk separately and did not have enough power to perform
analyses on milk with different fat contents. Furthermore, we
had a modest number of rectal cancer cases. We had informa-
tion about vitamin D intake from cod liver oil, but lacked
information on vitamin D from other supplements and Ca
supplement use. Residual confounding from vitamin D and Ca
can therefore not be excluded. As the present study is a
Table 2. Percentage of women in the milk intake groups* at baseline and
follow-up (n 47 583) in the Norwegian Women and Cancer Cohort Study
Milk intake group at follow-up
Milk intake groups at baseline No/seldom Low Medium High Total
No/Seldom 17 4 1 <1 21
Low 9 16 4 2 32
Medium 3 7 7 3 20
High 2 6 6 13 27
Total 30 34 17 19 100
* Milk intake group: no/seldom: 0 (no/seldom); low: >no/seldom to ≤165g/d;
medium: >165g/d to ≤240g/d; high: >240g/d.
Table 3. Selected characteristics of the study sample (n 81 675) and colorectal (CRC), colon and rectal cancer cases at baseline (1996–2005) in the
Norwegian Women and Cancer Cohort Study
(Medians and 5th–95th percentiles; numbers of cases; percentages)










Number of CRC cases, repeated measurements
analyses
872 617 255
Number of CRC cases, baseline data analyses 1084 771 313
Age at baseline, median (5th–95th percentile) 51 42–63 54 45–67 54 45–68 54 45–67
BMI at baseline, median (5th–95th percentile) 24 20–32 24 20–32 24 20–33 24 20–32
Smoking at baseline (%)
Never 36 33 33 33
<30 years 45 45 45 44
≥30 years 18 22 22 23
Physical activity level at baseline (%)*
Low 13 15 15 16
Medium 73 72 72 71
High 15 13 13 14
Duration of education at baseline (%)†
<10 years 24 34 36 29
10–12 years 35 34 34 31
>12 years 41 32 29 40
Total milk intake at baseline (g/d) 165 0–525 165 0–600 165 0–525 150 0–600
Ca from foods at baseline (mg/d)‡ 704 336–1320 670 327–1286 673 324–1281 666 327–1357
Ca from milk at baseline (mg/d) 165 0–525 165 0–600 165 0–525 150 0–600
Ca from foods other than dairy products at
baseline (mg/d)§
323 183–525 313 178–511 309 178–509 324 179–518
Vitamin D from foods other than vitamin-D-fortified
milk (µg/d)||
5·9 1·9–28·0 6·1 2·1–28·0 6·0 2·1–28·5 6·3 2·1–27·4
* n 72071 at baseline.
† n 77206 at baseline.
‡ Milk is included in Ca from foods.
§ Dairy products= total milk + hard white cheese+ yogurt.
|| Vitamin D from cod liver oil is included in vitamin D from foods.
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prospective cohort study, we can rule out the most serious
concerns of information and selection bias. Nevertheless,
selection bias may have occurred, as not all of the women who
were invited to complete a follow-up questionnaire returned it.
However, we have no reason to believe that any association
between milk intake and the risk of CRC differs between par-
ticipants who return follow-up questionnaires and those who
do not. Reverse causality owing to changes in food consump-
tion before CRC diagnosis may have biased the estimates in
either direction. However, analyses excluding CRC cases that
occurred within 1 year of baseline, and, in the repeated mea-
surements analyses, also excluding CRC cases occurring within
1 year of follow-up, hardly altered the risk estimates. We
adjusted for many of the common risk factors for CRC, and the
differences between the age-adjusted multivariable model and
energy-adjusted multivariable model were mostly minor.
Nevertheless, residual confounding owing to unknown or
imprecisely assessed confounders cannot be ruled out. Physical
activity is a risk factor for CRC(3), and thus our information on
physical activity level may be of particular concern, as it had the
highest fraction of missing values.
In our study, almost half of the women with measurements
from two points in time changed their milk intake, with 33%
moving to a lower milk intake group. This finding is in line with
what has been observed in national diet surveys among adult
Norwegian women(30,31). In the surveys conducted in 1993–
1994, 1997 and 2010–2011, the mean milk intake was 383, 332
and 187 g/d, respectively(30,31). According to Food Dis-
appearance Data, milk intake halved in Norway between 1953–
1955 and 2011(16).
Lack of repeated dietary measurements may contribute to
inconsistency in the results of observational studies(32). To the
best of our knowledge, only a few studies have used informa-
tion on milk intake from more than one point in time when
investigating the association between milk intake and risk of
CRC(32–34), and they did not use the same analytical approach as
we did. As we lack information on milk intake from two points
in time for a portion of the study sample, the number of CRC
Table 4. Risk of colorectal cancer (CRC), colon cancer and rectal cancer according to milk intake using repeated measurements analyses and baseline
data analyses in the Norwegian Women and Cancer Cohort Study (n 81 675)
(Hazard ratios (HR) and 95% confidence intervals)
Milk intake group*
Low Medium High
Total No/seldom HR 95% CI HR 95% CI HR 95% CI Pfor linear trend
Repeated measurements analyses
Person-years 922 583 244 546 302 668 169490 205879
CRC
Cases 872 245 300 156 171
Age-adjusted model 1·00 0·92 0·78, 1·09 0·86 0·70, 1·05 0·81 0·66, 0·98 0·04
Multivariable model† 1·00 0·93 0·78, 1·10 0·87 0·71, 1·07 0·82 0·67, 1·00 0·05
Energy-adjusted multivariable model‡ 1·00 0·94 0·79, 1·11 0·89 0·72, 1·09 0·85 0·69, 1·05 0·14
Colon cancer
Cases 617 173 219 111 114
Age-adjusted model 1·00 0·94 0·77, 1·15 0·85 0·67, 1·08 0·75 0·59, 0·95 0·01
Multivariable model 1·00 0·94 0·77, 1·15 0·87 0·68, 1·11 0·76 0·60, 0·97 0·02
Energy-adjusted multivariable model 1·00 0·95 0·78, 1·17 0·89 0·69, 1·13 0·80 0·62, 1·03 0·07
Rectal cancer
Cases 255 72 81 45 57
Age-adjusted model 1·00 0·88 0·64, 1·20 0·88 0·60, 1·27 0·94 0·67, 1·34 0·95
Multivariable model 1·00 0·89 0·65, 1·22 0·88 0·61, 1·29 0·95 0·67, 1·35 0·95
Energy-adjusted multivariable model 1·00 0·90 0·65, 1·24 0·89 0·61, 1·31 0·97 0·67, 1·42 0·92
Baseline data analyses
Person-years 1 059 797 236 869 336 687 206430 279811
CRC
Cases 1084 244 378 203 259
Age-adjusted model 1·00 0·97 0·83, 1·14 0·82 0·68, 0·99 0·75 0·63, 0·90 <0·01
Multivariable model 1·00 0·98 0·84, 1·16 0·84 0·69, 1·01 0·77 0·64, 0·92 <0·01
Energy-adjusted multivariable model 1·00 0·99 0·84, 1·16 0·84 0·69, 1·01 0·78 0·64, 0·94 <0·01
Colon cancer
Cases 771 167 266 151 187
Age-adjusted model 1·00 0·99 0·81, 1·20 0·87 0·70, 1·09 0·78 0·63, 0·96 <0·01
Multivariable model 1·00 1·00 0·82, 1·22 0·90 0·72, 1·12 0·80 0·65, 0·99 0·01
Energy-adjusted multivariable model 1·00 1·00 0·83, 1·22 0·90 0·72, 1·13 0·81 0·64, 1·01 0·03
Rectal cancer
Cases 313 77 112 52 72
Age-adjusted model 1·00 0·95 0·71, 1·27 0·70 0·49, 1·00 0·70 0·51, 0·97 0·02
Multivariable model 1·00 0·95 0·71, 1·27 0·70 0·49, 1·00 0·70 0·51, 0·97 0·02
Energy-adjusted multivariable model 1·00 0·95 0·71, 1·28 0·70 0·49, 1·01 0·71 0·50, 1·01 0·03
* Milk intake group: no/seldom: 0 (no/seldom); low: >no/seldom to ≤165g/d; medium: >165g/d to ≤240g/d; high: >240g/d.
† Age as the time scale and adjusted for BMI, smoking, processed meat, red meat, hard white cheese, yogurt, fibre from foods, alcohol.
‡ Age as the time scale and adjusted for BMI, smoking, processed meat, red meat, hard white cheese, yogurt, fibre from foods, alcohol, energy intake.
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cases was higher in the baseline data analyses than in repeated
measurements analyses. The higher statistical strength owing to
more CRC cases is a benefit for our baseline data analyses. On
the other hand, the fraction of women misclassified for milk
intake in these analyses will increase over time owing to the
change in milk intake. The advantage of repeated measure-
ments analyses is that they better take into account changes in
milk consumption. To the best of our knowledge, it is not
known at what stage in the carcinogenic process milk intake
may have the strongest impact on CRC development.
The analyses on colon cancer and rectal cancer in the sub-
sample of women with complete data on milk intake from two
points in time support the results that were observed in the total
study sample. The advantages of performing the analyses in this
subsample of women were that the follow-up time and number
of colon and rectal cancer cases were the same in repeated
measurements analyses and baseline data analyses; the dis-
advantage was that we did not use all the available information
on milk intake or other variables, as not all the women in the
study sample were included in these analyses.
Cohort studies on the association between milk intake
and the risk of CRC have reported different results(33–49).
A Norwegian study found no association between milk intake
and colon cancer among women(47). A protective effect of milk
on colon cancer was found for both sexes combined in a recent
meta-analysis(4), but not when the analyses were restricted to
women in this and in another meta-analysis(4,5). An inverse
association between milk intake and colon cancer risk was
found among women in an EPIC study(50); our results may
indicate the same. When it comes to milk intake and the risk of
rectal cancer, we found no association in repeated measure-
ments analyses, but indications of an inverse association in
baseline data analyses were observed. Different results
regarding milk intake and the risk of rectal cancer have been
found. A protective effect of milk on rectal cancer was found
among women in one meta-analysis(4), but not in another(5) or
in the EPIC study(50). Different genetic features between colon
and rectal cancers have been observed(51), and it has been
suggested that the aetiological factors may differ between colon
and rectal cancer(52). It is possible that milk does not have the
same effect on colon and rectal cancer risk(53).
The Ca content in dairy products is the main hypothesis for
the possible protective effect of dairy products on CRC(4).
According to the World Cancer Research Fund International/
American Institute for Cancer Research, there is probable evi-
dence that Ca supplements decrease the risk of CRC(3) and a
recent review classified the association between Ca and CRC
risk as highly suggestive(54). Both non-fermented and fermented
milk are good sources of Ca(5,55), and our results indicate that
milk was an important source of Ca in our study. This is in line
with the results from a national diet survey among Norwegian
adults in 2010–2011(31), in which milk accounted for 27% of Ca
from foods. It has been proposed that Ca affects proliferation,
differentiation and apoptosis in the colon(56–58). Different levels
of Ca(32,39,43), and threshold levels (approximately 1000–
1400mg/d)(46,59) of Ca, have been suggested to protect against
colon cancer. In our study, the median intake of Ca from foods
and Ca from milk in the high milk intake group was 1052 and
Table 5. Risk of colon and rectal cancer according to milk intake using repeated measurements analyses and baseline data analyses in a subsample in the
Norwegian Women and Cancer Cohort Study (n 49 274)
(Hazard ratios (HR) and 95% confidence intervals)
Milk intake group*
Low Medium High
Total No/seldom HR 95% CI HR 95% CI HR 95% CI Pfor linear trend
Colon cancer
Repeated measurements analyses
Person-years 692 663 179 390 229 347 127981 155 945
Cases 440 123 155 87 75
Multivariable model† 1·00 0·88 0·69, 1·12 0·92 0·70, 1·21 0·69 0·51, 0·92 0·02
Energy-adjusted multivariable model‡ 1·00 0·89 0·70, 1·14 0·94 0·71, 1·24 0·72 0·53, 0·99 0·06
Baseline data analyses
Person-years 692 663 142 142 219 636 138469 192 416
Cases 440 89 150 96 105
Multivariable model 1·00 0·96 0·74, 1·25 0·94 0·70, 1·26 0·72 0·54, 0·96 0·01
Energy-adjusted multivariable model 1·00 0·98 0·75, 1·28 0·96 0·72, 1·29 0·76 0·56, 1·04 0·05
Rectal cancer
Repeated measurements analyses
Person-years 692 663 179 390 229 347 127981 155 945
Cases 182 52 56 36 38
Multivariable model 1·00 0·81 0·55, 1·18 0·93 0·61, 1·43 0·82 0·54, 1·25 0·59
Energy-adjusted multivariable model 1·00 0·80 0·54, 1·17 0·91 0·59, 1·41 0·78 0·49, 1·23 0·48
Baseline data analyses
Person-years 692 663 142 142 219 636 138469 192 416
Cases 182 42 63 33 44
Multivariable model 1·00 0·90 0·61, 1·33 0·73 0·46, 1·15 0·67 0·44, 1·04 0·06
Energy-adjusted multivariable model 1·00 0·88 0·59, 1·31 0·71 0·45, 1·13 0·63 0·40, 1·00 0·05
* Milk intake group: no/seldom: 0 (no/seldom); low: >no/seldom to ≤165g/d; medium: >165g/d to ≤240g/d; high: >240g/d.
† Age as the time scale and adjusted for BMI, smoking, processed meat, red meat, hard white cheese, yogurt, fibre from foods, alcohol.
‡ Age as the time scale and adjusted for BMI, smoking, processed meat, red meat, hard white cheese, yogurt, fibre from foods, alcohol, energy intake.
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525mg/d at baseline, respectively. We also adjusted for two
other dairy products containing Ca (hard white cheese and
yogurt), and Ca from foods other than milk, hard white cheese
and yogurt, without this affecting the risk estimates. We could
not adjust for Ca supplement use. However, in a subsample of
women in the NOWAC Study, Ca was not among the three most
popular supplement ingredients(60).
Vitamin D affects the absorption of Ca in the gut(61) and there
may be an inverse association between vitamin D and the risk
of CRC(62). Owing to the links between Ca and vitamin D, we
adjusted for vitamin D from cod liver oil (we had no information
on vitamin D from other supplements) and from foods other
than vitamin-D-fortified milk, but this did not affect the risk
estimates for milk intake.
Milk also contains constituents other than Ca, which may
have a role in cancer prevention(61,63), such as linoleic acid and
sphingolipids(12,13). Constituents found in fermented milk may
also affect carcinogenesis(10,11). Owing to the differences in
non-fermented and fermented milk, it is possible that these
dairy products have different preventive effects against CRC(5).
However, based on our knowledge about Norwegian food
habits and unpublished data from the 24-h dietary recalls per-
formed in NOWAC in 2002(20), we assume that most of the milk
consumed in our study is non-fermented, and therefore we
presume that non-fermented milk contributed most to the
results in the present study.
The women in the present study have been randomly sam-
pled from the entire Norwegian female population, and no
major source of selection bias has been found that could
seriously threaten generalisation of the results to the source
population(21,22). Generalisation of the results to female popu-
lations outside of Norway may be affected by, for instance,
ethnicity(4,64), age and level of milk intake. Generalisation of the
results to men may be affected by sex differences.
Conclusion
The present study, which used two different analytical
approaches (repeated measurements analyses and baseline
data analyses), indicates that there may be a weak inverse
association between milk intake and risk of colon among
women. For rectal cancer, and hence CRC, different results
were found depending on the analytical approach. Our study
suggests that further attention ought to be given to the use of
single or repeated measurements when investigating the asso-
ciation between milk intake and the risk of CRC, colon cancer
and rectal cancer.
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